Schedule 13G ownership disclosure
PharmaCyte Biotech, Inc.
Security class unavailable · CUSIP: 17512X203
Event date: 2021-08-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,063,210
- Percent of class
- 6.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-21-045460
- Form type
- SC 13G
- Filer
- INTRACOASTAL CAPITAL, LLC
- CIK
- CIK 1646799
- Filed
- Aug 30, 2021
- Reporting period
- Aug 19, 2021
- Description
- Schedule 13G beneficial ownership